Stock chart
Ticker: ANGO Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-01-17 2025-01-16 S Sale

Nighan Warren JR

SVP Quality and Regulatory

Officer
4,060 -8.8%
12.31
USD 49,979
4,060 -8.8% 12.31 USD 49,979
2024-10-10 2024-10-10 B Purchase

Nighan Warren JR

SVP Quality and Regulatory

Officer
100 +0.2%
6.08
USD 608
100 +0.2% 6.08 USD 608
2024-10-08 2024-10-08 B Purchase

Trowbridge Stephen A

EVP and CFO

Officer
1,700 +1.0%
5.86
USD 9,962
1,700 +1.0% 5.86 USD 9,962
2024-10-10 2024-10-07 B Purchase

Nighan Warren JR

SVP Quality and Regulatory

Officer
768 +1.7%
6.09
USD 4,677
768 +1.7% 6.09 USD 4,677
2024-10-08 2024-10-07 B Purchase

Clemmer James C

President and CEO

Executive Director
20,000 +3.0%
6.03
USD 120,600
20,000 +3.0% 6.03 USD 120,600
2024-04-08 2024-04-08 B Purchase

Clemmer James C

President and CEO

Executive Director
10,000 +1.9%
6.70
USD 67,000
10,000 +1.9% 6.70 USD 67,000
2023-02-01 2023-01-31 S Sale

Helsel Dave

SVP Global Operations and R&D

Officer
4,633 -19.4%
12.95
USD 59,997
4,633 -19.4% 12.95 USD 59,997
2022-10-12 2022-10-12 B Purchase

Trowbridge Stephen A

EVP and CFO

Officer
1,083 +1.2%
13.82
USD 14,967
1,083 +1.2% 13.82 USD 14,967
2022-10-11 2022-10-10 B Purchase

Clemmer James C

President and CEO

Executive Director
10,000 +2.3%
15.00
USD 150,000
10,000 +2.3% 15.00 USD 150,000
2022-08-01 2022-07-29 S Sale

Helsel Dave

SVP Global Operations and R&D

Officer
5,000 -17.3%
22.44
USD 112,200
5,000 -17.3% 22.44 USD 112,200
2022-05-02 2022-04-28 S Sale

Helsel Dave

SVP Global Operations and R&D

Officer
3,513 -13.3%
22.44
USD 78,832
3,513 -13.3% 22.44 USD 78,832
2022-04-13 2022-04-12 S Sale

JOHNSON WESLEY

Non-Executive Director
1,299 -1.6%
23.26
USD 30,215
1,299 -1.6% 23.26 USD 30,215
2022-04-13 2022-04-11 S Sale

JOHNSON WESLEY

Non-Executive Director
6,201 -7.2%
23.00
USD 142,623
6,201 -7.2% 23.00 USD 142,623
2022-01-12 2022-01-12 B Purchase

Trowbridge Stephen A

EVP and CFO

Officer
1,000 +1.3%
22.64
USD 22,640
1,000 +1.3% 22.64 USD 22,640
2022-01-12 2022-01-11 B Purchase

Clemmer James C

President and CEO

Executive Director
10,000 +2.6%
22.84
USD 228,400
10,000 +2.6% 22.84 USD 228,400
2021-10-21 2021-10-20 S Sale

Helsel Dave

SVP Global Operations and R&D

Officer
3,494 -11.7%
27.97
USD 97,727
3,494 -11.7% 27.97 USD 97,727
2021-10-18 2021-10-15 S Sale

Centea Scott

Sr. VP/GM, Global VIT

Officer
12,000 -20.6%
27.92
USD 335,040
12,000 -20.6% 27.92 USD 335,040
2021-10-06 2021-10-05 S Sale

Campbell Chad Thomas

SVP/GM, Vascular Access

Officer
10,748 -25.3%
27.15
USD 291,808
10,748 -25.3% 27.15 USD 291,808
2021-04-15 2021-04-14 S Sale

Helsel Dave

SVP Global Operations and R&D

Officer
3,500 -15.5%
23.93
USD 83,755
3,500 -15.5% 23.93 USD 83,755
2021-01-21 2021-01-20 S Sale

JOHNSON WESLEY

Non-Executive Director
6,500 -7.7%
18.53
USD 120,445
6,500 -7.7% 18.53 USD 120,445
// ... existing code ...